Estudo comparativo entre a atividade terapêutica da imida ftálica do acido glutâmico e a atividade terapêutica da triancinolona no tratamento da reação hansênica da hanseniase virchowiana

Authors

  • Estevam de Almeida Neto Estudo comparativo entre a atividade terapêutica da imida ftálica do ácido glutâmico e a atividade terapêutica da triancinolona no tratamento da reação hansênica da hanseníase virchowiana.

DOI:

https://doi.org/10.47878/hi.1981.v6.36114

Keywords:

Virchowian hanseniasis, Hansenic reaction, Comparative therapeutic activity, Thalidomide, Triancinolone

Abstract

A study was made in twenty inpatients of the "Hospital das Clínicas" of the "Faculdade de Medicina da Universidade de Silo Paulo" in order to compare the short-term activities of the Brazilian made imidphtalic
glutamic acid and of the triancinolone in the therapy of the hansenic reaction of the Virchowian hanseniasis (in the erythema nodosum and in the erythema multiform syndromes as well). In this research it was observed that the therapeutic activities of both drugs present a perfect and undeniable equivalence and that their use have reduced the period of hospitalization to 8,3 days per each patient.

Downloads

Download data is not yet available.

References

1 BALIÑA, L.M.; GATTI, J.C.; CARDA- MA, J.E.; AVILA, J.J. La talidomida en loa episodios reaccionales de la lepra.
Leprologia, 14(2):189-193, 1969.
2 CALVO, R. ,& MÜ CKTER, H. Sur le mécanisme d'action de la thalidomide et autres imides cycliques dana la réaction lépreuse. Acta Leprol., (48/ 49) :27-29, 1972.
3 CHEYMOL, J. Le drame du thalidomide. Rev. Assoc. Med. Bras., 11(4) : 123-134, 1965.
4 DANIELSSEN, D.C. & BOECK, W. Traité de la spédalskhed ou élephantiasis des grecs. Paris, Baillière, 1848. 535p.
5 GOUGEROT, H. Lèpre. In: DARIER, J. et al. Nouvelle pratique dermatologique. Paris, Masson, 1936. v. 3, p. 841-921.
6 HAEUSLER, E.V. ACTH y cortisona. Antióquia Med., 8(2) :45-96, 1952.
7 JEANSELME, E. La lèpre. Paris, Doin, 1934, 679p.
8 LELOIR, H. Traité pratique of théorique de la Lèpre. Paris, Progrès Medical, 1886. 359p.
9 LOWE, J. A.C.T.H. and cortisone in leprosy. Brit. Me00d. J., (4758):601, 1952.
10 ROCHE, M.; CONVIT, J.; MEDINA,J.A. ; BLOMENFELD, E. The effects of the adrenocorticotropic hormone (ACTH) in lepromatous lepra reaction. /nt. J. Lepr., 19(2): 137-145, 1951.
11 SAGHER, F. & SHESKIN, J. Réaction lépreuse et thalidomide — Etude des immunologiques. Acta Leprol., (48/ 49) :11-25, 1972.
12 SHESKIN, J. Influencia de la talidomida en la reaction leprosa. Dorm. Vence., 4(3/4) :210-221, 1964/1965.
13 SHESKIN, J. Further observation with thalidomide in lepra reactions. Lepr. Rev., 86 (4) :183-187, 1965.
14 SHESKIN, J. Thalidomide in the treatment of lepra reactions. Clin. Pharmacol. Ther., 6:303, 1965.
15 SHESKIN, J. Fifty months' use of thalidomide in leprosy reaction. Star, 28 (6) :3, 1969.
16 SHESKIN, J Incorporación de la talidomida al arsenal terapéutico del mal de Hansen. Actas Dermosifiliogr., 60(3/4):57-72, 1969.
17 SOUZA LIMA, L. & MAURANO, F. Reação leprótica. Rio de Janeiro, Serviço Nacional de Lepra, 1949. 157p.

Published

1981-11-30

How to Cite

1.
Almeida Neto E de. Estudo comparativo entre a atividade terapêutica da imida ftálica do acido glutâmico e a atividade terapêutica da triancinolona no tratamento da reação hansênica da hanseniase virchowiana. Hansen. Int. [Internet]. 1981 Nov. 30 [cited 2024 May 15];6(2):114-21. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/36114

Issue

Section

Original articles